IGF-1 DES: Comparing the Two Major Truncated Analogues IGF-1 DES (des(1-3)-IGF-1) lacks the first three N-terminal amino acids of native IGF-1
To cope with this burden a fit, rested, a well-fed person must maintain adequate immunological and biochemical defense
Many factors can interfere with this process
Medical supervision ensures safe administration and monitoring of both desired effects and potential side effects
There are three variables that govern how severe your die-off symptoms will be: How many bacteria are dying: The more bacteria, the bigger the burden your body has to manage
More serious but less common risks include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal symptoms), and diabetic retinopathy complications, particularly in patients with pre-existing retinopathy who experience rapid improvement in blood glucose